Literature DB >> 7633613

Simple and specific reversed-phase liquid chromatographic method with diode-array detection for simultaneous determination of serum hydroxychloroquine, chloroquine and some corticosteroids.

P Volin1.   

Abstract

This paper describes a simple, specific, and sensitive high-performance liquid chromatographic (HPLC) method using ion-pair reversed-phase chromatography with photodiode-array detection for the simultaneous determination of hydroxychloroquine (HCQ) and chloroquine (CQ) in serum samples from rheumatoid arthritis patients receiving either HCQ sulphate or CQ diphosphate. The assay is also applicable to the simultaneous determination of corticosteroids. The method consisted of two diethyl ether extractions of 1.0 ml of serum, to which two internal standards (2,3-diaminonaphthalene and 18-hydroxy-11-deoxycorticosterone) and 1.0 ml of 0.25 M sodium hydroxide had been added. After the organic phase was evaporated to dryness at 30-40 degrees C under a stream of nitrogen, the extract was reconstituted with a 1:1 mixture of 0.1 M perchloric acid and methanol, an aliquot of which was injected on to the system. Peak-height ratios at different wavelengths (A245/343, A245/256, A245/265 and A245/275) were utilized as a method of assessing peak homogeneity. Some anti-inflammatory drugs which may be used for rheumatic disorders were shown not to interfere with the assay. The method provides selectivity by using diode-array detection at several wavelengths. The use of two internal standards not only compensates for losses during the sample manipulation but also prevents erroneous results in case of interference.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7633613     DOI: 10.1016/0378-4347(94)00584-r

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  6 in total

1.  Stability Indicating LC Method Development for Hydroxychloroquine Sulfate Impurities as Available for Treatment of COVID-19 and Evaluation of Risk Assessment Prior to Method Validation by Quality by Design Approach.

Authors:  Thirupathi Dongala; Naresh Kumar Katari; Ashok Kumar Palakurthi; Lakshmi Narasimha Rao Katakam; Vishnu Murthy Marisetti
Journal:  Chromatographia       Date:  2020-08-25       Impact factor: 2.044

Review 2.  HPLC methods for choloroquine determination in biological samples and pharmaceutical products.

Authors:  Yugo Araújo Martins; Talita Mota Gonçalves; Renata F V Lopez
Journal:  Daru       Date:  2021-03-19       Impact factor: 3.117

3.  Development and Validation of a Simple and Rapid Ultrahigh-Performance Liquid Chromatography Tandem Spectrometry Method for the Quantification of Hydroxychloroquine in Plasma and Blood Samples in the Emergency Context of SARS-CoV-2 Pandemic.

Authors:  Natalia Doudka; Madeleine Giocanti; Manon Basso; Renée Ugdonne; Karine Barthelemy; Bruno Lacarelle; Olivier Blin; Caroline Solas; Romain Guilhaumou
Journal:  Ther Drug Monit       Date:  2021-08-01       Impact factor: 3.681

4.  Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine.

Authors:  Yufei Chen; Yannick Leandre Traore; Amanda Li; Keith R Fowke; Emmanuel A Ho
Journal:  Drug Des Devel Ther       Date:  2014-10-09       Impact factor: 4.162

5.  Cyclodextrin-mediated gold nanoparticles as multisensing probe for the selective detection of hydroxychloroquine drug.

Authors:  Jaise Mariya George; Beena Mathew
Journal:  Korean J Chem Eng       Date:  2021-03-05       Impact factor: 3.309

6.  Development and Validation of Reversed-Phase High Performance Liquid Chromatographic Method for Hydroxychloroquine Sulphate.

Authors:  A Singh; C L Singh; R Gupta; S Kumar; M Kumar
Journal:  Indian J Pharm Sci       Date:  2015 Sep-Oct       Impact factor: 0.975

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.